Analytics

Also, AIM will be collaborating with Stanford Medicine to validate its diagnostic endoscopic AI.

HIMSS23 attendees discuss the conference post-pandemic, how attending helps explore new pathways for their company, and what technologies they look forward to learning about most on the exhibit floor.

Edward Yurcisin, chief technology officer at NCQA, tells how health plans and organizations can improve healthcare quality by utilizing open-source innovation between payers and providers and how NCQA works to help them achieve that goal.

It uses a competitive learning approach against unlabelled data. 

Freddie Feldman, director of voice and conversational interfaces at Wolters Kluwer, talks about the potential of using AI and natural language processing for voice interfaces, and about limitations in the answers that generative AI can provide.

Dr. Payel Das, principal research staff member and manager in the Trusted AI department of IBM, and an IBM master inventor, relays how using large language models that fill gaps in datasets may improve drug discovery in the future.

Also, Fujifilm is reorganising its Medical Systems business units.

Explore HIMSS23 exhibit floor and what experiences and technologies companies are using to improve the patient and provider experience, including real and animated animal-based therapy, and digitized white boards with patient information.

David Chen, Shine Technology's director of business development, talks about how HIMSS23 affords him the opportunity to learn more about AI and other cutting-edge digital technologies, and to network with organizations regarding his company's devices.

Naomi Fried, founder and CEO of PharmStars, discusses the 13 startups from its spring cohort and its call for applications for its fall 2023 cohort, Digital Innovations in Therapeutic Delivery: Supply Chain to the Patient Interface.